Pharma Expo To Be Held In Noida From Nov 28-30

(MENAFN- KNN India) Noida, Nov 21 (KNN) The 16th edition of CPHI & PMEC India Expo will be held at the India Expo Mart and Centre in Greater Noida from November 28-30.

Informa Markets said the expo will bring together over 45,000 visitors, 1,500 exhibitors showcasing 10,000 plus products and provide a unique environment for industry experts to meet, learn, share ideas and drive their business forward.
The pharma expo aims to spotlights technological strides pivotal in propelling India's pharmaceutical machinery, technology, and ingredients sectors.

The Indian pharmaceutical industry, on the brink of significant expansion, eyes a projected CAGR of 13 per cent, eyeing a market value of USD 102.7 billion (Rs 8.5 lakh crore) by 2028, according to a statement.

Yogesh Mudras, Managing Director, Informa Markets in India said, "In 2023, the Indian pharma industry is experiencing the 'Rise and Rise of India' a perfect blend of a strong domestic manufacturing base, increasing innovation, and robust government support.”

"With objectives laid down during the G20 presidency, the industry in India is poised to scale to USD 65 billion by 2024 and surpass USD 130 billion by 2030, driven by heightened pharmaceutical innovation, technological advancements, and a focus on breakthrough products," he said.

Mudras said a vaccine manufacturing powerhouse, India leads by supplying over 60 per cent of global vaccine demand.

"The future involves a growing production capacity, collaboration with private players, and a commitment to training 30 million professionals in digital skills by 2026," he added.

(KNN Bureau)


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.